Cargando…

How to Interpret and Pursue an Abnormal Complete Blood Cell Count in Adults

A complete blood cell count (CBC) is one of the most common laboratory tests in medicine. For example, at our institution alone, approximately 1800 CBCs are ordered every day, and 10% to 20% of results are reported as abnormal. Therefore, it is in every clinician's interest to have some underst...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tefferi, Ayalew, Hanson, Curtis A., Inwards, David J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Mayo Foundation for Medical Education and Research. Published by Elsevier Inc. 2005
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7127472/ https://www.ncbi.nlm.nih.gov/pubmed/16007898 http://dx.doi.org/10.4065/80.7.923

Ejemplares similares

How to pursue EPO in MS
por: Bartels, Claudia, et al.
Publicado: (2017)

Pursuing interpretations of the HERA large-$Q^{2}$ data
por: Altarelli, Guido, et al.
Publicado: (1997)

Pursuing the Strange Stop Interpretation of the HERA Large $Q^2$ data
por: Ellis, Jonathan Richard, et al.
Publicado: (1997)

Cytogenetic abnormalities in essential thrombocythemia: Clinical and molecular correlates and prognostic relevance in 809 informative cases
por: Gangat, Naseema, et al.
Publicado: (2022)

The pursue of quality
por: Araujo, Eustaquio
Publicado: (2015)

Pursuing the Mission: How Homeless Veterans Manage Chronic Disease
por: Weber, Jillian, et al.
Publicado: (2018)

Are Leukocyte and Platelet Abnormalities and Complete Blood Count Ratios Potential Prognostic Markers in Canine Sepsis?
por: Pierini, Alessio, et al.
Publicado: (2020)

Pursuing better PVCs.
Publicado: (1997)

Faint, Yet Pursuing
Publicado: (1861)

Clustering of blood cell count abnormalities and future risk of death
por: Patti, Giuseppe, et al.
Publicado: (2021)

Abnormal peripheral blood cell counts in neurofibromatosis type 1
por: Nobeyama, Yoshimasa, et al.
Publicado: (2022)

Myeloma therapy: pursuing the plasma cell
por: Cavenagh, J
Publicado: (2010)

World Health Organization class-independent risk categorization in mastocytosis
por: Pardanani, Animesh, et al.
Publicado: (2019)

HemoScreen hematology analyzer compared to Sysmex XN for complete blood count, white blood cell differential, and detection of leukocyte abnormalities
por: Linko‐Parvinen, Anna‐Maria, et al.
Publicado: (2022)

1.5 million platelet count limit at essential thrombocythemia diagnosis: correlations and relevance to vascular events
por: Gangat, Naseema, et al.
Publicado: (2022)

Complete Blood Count Reference Intervals for Healthy Han Chinese Adults
por: Wu, Xinzhong, et al.
Publicado: (2015)

Association between telomere length and complete blood count in US adults
por: Mazidi, Mohsen, et al.
Publicado: (2017)

Validation of the WHO-defined 20% circulating blasts threshold for diagnosis of leukemic transformation in primary myelofibrosis
por: Mudireddy, Mythri, et al.
Publicado: (2018)

Pursuing professional development : the self as source /
por: Bailey, Kathleen M.

Deviation from Normal Values of Leukocyte and Erythroblast Parameters in Complete Blood Count is a Messenger for Platelet Abnormalities
por: Beyan, Cengiz, et al.
Publicado: (2014)

Pursuing the middleman: the hunt for integrins
por: Powell, Kendall
Publicado: (2005)

Complete blood cells count abnormalities in COVID-19 patients and their prognostic significance: Single center study in Makkah, Saudi Arabia
por: Abd El-Lateef, Amal E., et al.
Publicado: (2022)

How useful are complete blood count and reticulocyte reports to clinicians in Addis Ababa hospitals, Ethiopia?
por: Birhaneselassie, Misganaw, et al.
Publicado: (2013)

The effect of taurine addition on the complete blood count
por: Yassin, Maged Mohammed
Publicado: (2013)

Complete Blood Count and Retinal Vessel Calibers
por: Liew, Gerald, et al.
Publicado: (2014)

Complete blood count alterations in disseminated histoplasmosis
por: Lunardi, Luciano Werle, et al.
Publicado: (2015)

Challenging the Interpretation of White Blood Cell Counts in Patients with Sepsis Following Packed Cell Transfusion †
por: Klein, Moti, et al.
Publicado: (2023)

Cold agglutinins revealed by abnormalities to the cell blood count: a case report
por: Zahid, Hafid, et al.
Publicado: (2021)

Normal karyotype in myelofibrosis: is prognostic integrity affected by the number of metaphases analyzed?
por: Nicolosi, Maura, et al.
Publicado: (2018)

Marked elevation of serum lactate dehydrogenase in primary myelofibrosis: clinical and prognostic correlates
por: Shah, Sahrish, et al.
Publicado: (2017)

Molecular drug targets in myeloproliferative neoplasms: mutant ABL1, JAK2, MPL, KIT, PDGFRA, PDGFRB and FGFR1
por: Tefferi, Ayalew
Publicado: (2009)

Anemia in myelofibrosis—prevalence, the U2AF1 connection, new treatments
por: Tefferi, Ayalew
Publicado: (2017)

Pursuing information literacy : roles and relationships
por: Lombard, Emmett
Publicado: (2010)

Pursuing supersymmetry in Z0 decays
por: Ellis, Jonathan Richard, et al.
Publicado: (1990)

Pursuing the impossible: an interview with Tim Hunt
por: Hunt, Tim
Publicado: (2015)

Intersecting barriers to pursuing clinical academia
por: Fisayo, Temitope
Publicado: (2021)

Association of complete blood cell counts with metabolic syndrome in an elderly population
por: Li, Peng-Fei, et al.
Publicado: (2016)

Complete blood cell count components and coronary slow-flow phenomenon
por: Arjmand, Nasim, et al.
Publicado: (2016)

Role of complete blood cell count parameters in the diagnosis of neonatal sepsis
por: Worku, Minichil, et al.
Publicado: (2022)

Predictions of CD4 lymphocytes’ count in HIV patients from complete blood count
por: Rodríguez, Javier O, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_4bhuj5fp2hj96k2ldbsq4rv7dc